Sign In
Last checked at 
28 Sep 2011 07:00
ο»Ώ
Β
For immediate release | 28 September 2011 |
Β
Β
Futura Medical plc
("Futura" or "the Company")
Grant of Options
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that on 28 September 2011 it granted options over a total of 700,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.
Director | Number of options granted | Exercise price | Exercise period | Total number of options held following notification | Total number of ordinary shares held |
W D Potter | 100,000 | 56.50p | 1 Oct 2013 - 30 Sep 2018 | 300,000 | 207,424 |
J H Barder | 250,000 | 56.50p | 1 Oct 2013 - 30 Sep 2018 | 700,000 | 870,330 |
D B Davies | 200,000 | 56.50p | 1 Oct 2013 - 30 Sep 2018 | 600,000 | 631,306 |
D A Martin | 150,000 | 56.50p | 1 Oct 2013 - 30 Sep 2018 | 550,000 | 225,000 |
Β
All options were granted under the Futura Medical plc Unapproved Share Option Scheme with the exception of 73,894 options granted to D A Martin which were granted under the Futura Medical plc Enterprise Management Incentive Scheme.
Β
The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.
Β
For any further information please contact:
Β
Futura Medical plc | Β |
James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
Β | Β |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
Β | Β |
Nomura Code Securities Limited | Β |
Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
Β | Β |
For media enquiries please contact: | Β |
Β | Β |
Buchanan Communications | Β |
Mark Court / Jessica Fontaine | Tel: +44 (0) 20 7466 5000 |
Β
Β
Notes to Editors
Β
Futura Medical plc
Β
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Β
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Β
www.futuramedical.com
Β
Follow the stocks
